Mirum Pharmaceuticals, Inc. — Director's Dealing 2021

Mar 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Mirum Pharmaceuticals, Inc. (MIRM)
CIK: 0001759425
Period of Report: 2021-03-05

Reporting Person: Tucker Edwin Jonathan (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-05	Common Stock	M	1082	$7.70	Acquired	37524	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-05	Stock Option (right to buy)	$7.70	M	1082	Disposed	2029-10-23	Common Stock (1082)	Direct

Footnotes

F1: 1/4th of the shares vest one year after October 24, 2019 and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of October 24, 2019.